ID

34292

Descrizione

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function; ODM derived from: https://clinicaltrials.gov/show/NCT02014259

collegamento

https://clinicaltrials.gov/show/NCT02014259

Keywords

  1. 16/01/19 16/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

16 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes NCT02014259

Eligibility Diabetes NCT02014259

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT02014259
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female aged 18-85 years (both inclusive) at the time of signing inform consent
Descrizione

ID.1

Tipo di dati

boolean

subject with normal renal function or renal impairment (mild, moderate, severe or end-stage renal disease requiring dialysis)
Descrizione

ID.2

Tipo di dati

boolean

for subject with normal renal function: good general health (as judged by the investigator)
Descrizione

ID.3

Tipo di dati

boolean

body mass index (bmi) 18.5-40.0 kg/m^2 (both inclusive)
Descrizione

ID.4

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using adequate contraceptive methods
Descrizione

ID.5

Tipo di dati

boolean

history of crohn's disease, ulcerative colitis, or other inflammatory bowel disease
Descrizione

ID.6

Tipo di dati

boolean

uncontrolled hypertension (defined as systolic blood pressure above or equal to 180 mmhg and/or diastolic blood pressure above or equal to 100 mmhg)
Descrizione

ID.7

Tipo di dati

boolean

any blood draw or donation of blood or plasma in excess of 400 ml within the 3 months preceding the screening visit (visit 2)
Descrizione

ID.8

Tipo di dati

boolean

history of significant drug abuse, or a positive drug test at the screening visit (visit 2)
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Diabetes NCT02014259

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT02014259
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male or female aged 18-85 years (both inclusive) at the time of signing inform consent
boolean
ID.2
Item
subject with normal renal function or renal impairment (mild, moderate, severe or end-stage renal disease requiring dialysis)
boolean
ID.3
Item
for subject with normal renal function: good general health (as judged by the investigator)
boolean
ID.4
Item
body mass index (bmi) 18.5-40.0 kg/m^2 (both inclusive)
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using adequate contraceptive methods
boolean
ID.6
Item
history of crohn's disease, ulcerative colitis, or other inflammatory bowel disease
boolean
ID.7
Item
uncontrolled hypertension (defined as systolic blood pressure above or equal to 180 mmhg and/or diastolic blood pressure above or equal to 100 mmhg)
boolean
ID.8
Item
any blood draw or donation of blood or plasma in excess of 400 ml within the 3 months preceding the screening visit (visit 2)
boolean
ID.9
Item
history of significant drug abuse, or a positive drug test at the screening visit (visit 2)
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial